Intetumumab

BIOLOGICAL2 trials

Sponsors

Centocor, Inc.

Conditions

MelanomaProstatic Neoplasms

Phase 1

A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma

CompletedNCT00246012

Centocor, Inc.Melanoma

Start: 2005-05-31End: 2009-02-28Updated: 2013-08-19

Phase 2

An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancer

CompletedNCT00537381

Centocor, Inc.Prostatic Neoplasms

Start: 2007-05-31End: 2009-11-30Updated: 2013-06-20